These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 39238647)

  • 1. Integrating single-cell transcriptomics to reveal the ferroptosis regulators in the tumor microenvironment that contribute to bladder urothelial carcinoma progression and immunotherapy.
    Chen Z; Hu J; Ou Y; Ye F; Li W; Liu S; Jiang H
    Front Immunol; 2024; 15():1427124. PubMed ID: 39238647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating single-cell RNA-seq to identify fibroblast-based molecular subtypes for predicting prognosis and therapeutic response in bladder cancer.
    Wang J; Tan Z; Huang Y; Li C; Zhan P; Wang H; Li H
    Aging (Albany NY); 2024 Jul; 16(14):11385-11408. PubMed ID: 39033778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing.
    Li T; Zhou Z; Xie Z; Fan X; Zhang Y; Zhang Y; Song X; Ruan Y
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11379-11395. PubMed ID: 37369799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell and bulk RNA-sequence identified fibroblasts signature and CD8 + T-cell - fibroblast subtype predicting prognosis and immune therapeutic response of bladder cancer, based on machine learning: bioinformatics multi-omics study.
    Li J; Kong Z; Qi Y; Wang W; Su Q; Huang W; Zhang Z; Li S; Du E
    Int J Surg; 2024 Aug; 110(8):4911-4931. PubMed ID: 38759695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoskeleton regulator RNA expression on cancer-associated fibroblasts is associated with prognosis and immunotherapy response in bladder cancer.
    Wu Y; Xu Y; He S; Li Y; Feng N; Fan J; Gong Y; Li X; Zhou L
    Heliyon; 2023 Mar; 9(3):e13707. PubMed ID: 36873531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Ferroptosis-Related lncRNA Signature to Predict the Prognosis and Immune Landscape of Bladder Cancer.
    Zhou R; Liang J; Tian H; Chen Q; Yang C; Liu C
    Dis Markers; 2021; 2021():1031906. PubMed ID: 34239619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated fibroblast-derived gene signature discriminates distinct prognoses by integrated single-cell and bulk RNA-seq analyses in breast cancer.
    Fang Z; Han YL; Gao ZJ; Yao F
    Aging (Albany NY); 2024 May; 16(9):8279-8305. PubMed ID: 38728370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis of multiple transcriptomic approaches and machine learning integration algorithms reveals high endothelial venules as a prognostic immune-related biomarker in bladder cancer.
    Zhang J; Huang Y; Tan X; Wang Z; Cheng R; Zhang S; Chen Y; Jiang F; Tan W; Deng X; Li F
    Int Immunopharmacol; 2024 Jul; 136():112184. PubMed ID: 38824904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weighted gene co-expression network analysis can sort cancer-associated fibroblast-specific markers promoting bladder cancer progression.
    Liu B; Zhan Y; Chen X; Hu X; Wu B; Pan S
    J Cell Physiol; 2021 Feb; 236(2):1321-1331. PubMed ID: 32657439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis-related long non-coding RNA signature predicts the prognosis of bladder cancer.
    Hou J; Lu Z; Cheng X; Dong R; Jiang Y; Wu G; Qu G; Xu Y
    BMC Cancer; 2022 Jun; 22(1):719. PubMed ID: 35768833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of single-cell ferroptosis regulation in intercellular communication and skin cutaneous melanoma progression and immunotherapy.
    Song B; Peng Y; Zheng Y; Zhu Y; Liu W; Wang K; Cui Z; Song B
    Cancer Immunol Immunother; 2023 Nov; 72(11):3523-3541. PubMed ID: 37638981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a T cell proliferation-associated regulator signature correlates with prognosis risk and immunotherapy response in bladder cancer.
    Yan T; Zhou W; Li C
    Int Urol Nephrol; 2024 Nov; 56(11):3447-3462. PubMed ID: 38789872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing a machine learning-based prognosis and immunotherapeutic response signature in colorectal cancer: insights from ferroptosis, fatty acid dynamics, and the tumor microenvironment.
    Zhu J; Zhang J; Lou Y; Zheng Y; Zheng X; Cen W; Ye L; Zhang Q
    Front Immunol; 2024; 15():1416443. PubMed ID: 39076986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated Fibroblasts in Bladder Cancer: Origin, Biology, and Therapeutic Opportunities.
    Caramelo B; Zagorac S; Corral S; Marqués M; Real FX
    Eur Urol Oncol; 2023 Aug; 6(4):366-375. PubMed ID: 36890105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single cell and bulk RNA sequencing identifies tumor microenvironment subtypes and chemoresistance-related IGF1
    Jia X; Li Z; Zhou R; Feng W; Yi L; Zhang H; Chen B; Li Q; Huang S; Zhu X
    Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167123. PubMed ID: 38484940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer.
    Wang W; Li T; Xie Z; Zhao J; Zhang Y; Ruan Y; Han B
    J Transl Med; 2024 Jan; 22(1):57. PubMed ID: 38221616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative analyses of bulk and single-cell RNA-seq identified cancer-associated fibroblasts-related signature as a prognostic factor for immunotherapy in NSCLC.
    Wang S; Fan G; Li L; He Y; Lou N; Xie T; Dai L; Gao R; Yang M; Shi Y; Han X
    Cancer Immunol Immunother; 2023 Jul; 72(7):2423-2442. PubMed ID: 37010552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results from a real-world study: a novel glycosyltransferase risk score for prognosis, tumor microenvironment phenotypes and immunotherapy in bladder cancer.
    Liu R; Yang T; Huang J; Xiao Z; Liu J; Li Z; Tong S
    BMC Cancer; 2024 Aug; 24(1):947. PubMed ID: 39095785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. POSTN
    Wang H; Liang Y; Liu Z; Zhang R; Chao J; Wang M; Liu M; Qiao L; Xuan Z; Zhao H; Lu L
    J Immunother Cancer; 2024 Jul; 12(7):. PubMed ID: 39067872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated Analysis Revealed an Inflammatory Cancer-Associated Fibroblast-Based Subtypes with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Bladder Cancer Patients.
    Chen H; Yang W; Xue X; Li Y; Jin Z; Ji Z
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.